Lumason 60.7 mg/mg

Lumason 60.7 mg/mg is a diagnostic imaging agent used to enhance ultrasound images. This lyophilized powder for suspension is administered intravenously or intravesically for improved visualization.

Lumason is primarily used as a contrast agent in ultrasound imaging. It helps to enhance the visibility of blood flow and tissue structures, aiding in the diagnosis of various conditions. The primary use of Lumason is to improve the clarity of ultrasound images, making it easier for healthcare professionals to identify abnormalities.

When administered, Lumason can enhance the contrast in ultrasound images, providing clearer visuals of blood vessels and tissues. This can help in the detection and evaluation of various medical conditions. The effects are typically temporary and related to the imaging procedure.

Lumason should be used with caution in patients with known allergies to sulfur hexafluoride or any of the components in the formulation. It is important to follow the prescribed administration guidelines and monitor patients for any adverse reactions during and after the procedure.

Lumason may interact with other medications or substances, particularly those that affect the cardiovascular system. It is advisable to inform healthcare professionals about all current medications before undergoing any diagnostic procedure involving Lumason.